Utah Jazz

Northwest | 0-0
  • Field Goal %
    44.9 FG%
  • 3-point %
    35.5 3P%
  • Points Scored
    98 PPG
  • Total Rebounds
    43.2 RPG
  • 51Q: Is there any reason the Jazz won’t be really good?
    ProBasketballTalk2 hours ago

    51Q: Is there any reason the Jazz won’t be really good?

    In the non-Warriors category, it’s hard to argue that very many teams had better offseasons than the Jazz when it comes to filling holes on their roster without giving up any core pieces. Utah’s weakest position last season was point guard — with Dante Exum out for the year rehabbing a torn ACL, things got so bad that a midseason trade for career backup Shelvin Mack was considered a major upgrade. This summer, they flipped a lottery pick they didn’t really want to Atlanta in a three-team deal that got them George Hill, as solid a starting-caliber point guard as would realistically be available for them. Hill’s playmaking and outside shooting immediately improve Utah’s offense and gives Snyder a rock-solid veteran to take pressure off Exum coming back from missing a full year of action.

  • ProBasketballTalk

    Rockets GM Daryl Morey: James Harden ‘only a polarizing figure to people who don’t watch’

    Do you struggle with evaluating James Harden? I know I do. Harden’s Rockets, projected by some to contend for a championship, struggled to a 41-41 record last season. A fair share of their downfall could be pinned on him. His defensive disinterest is appalling, and it sets a tone. His leadership is questionable, which matters a great deal for someone so empowered. He relies on tricking referees to draw fouls, frequently hooking his defender to create contact. But I still put him on my All-NBA team, because his offense was so darned effective. Elite individual offensive contributions are incredibly valuable. Harden’s defensive shortcomings can be hidden in a better team scheme. His leadership

  • Trail Blazers C Festus Ezeli out six weeks after knee injection

    Trail Blazers C Festus Ezeli out six weeks after knee injection

    At one point, Festus Ezeli was predicted to land $50 million over three years in free agency. But even in this wild market, injury concerns forced him to settle for just $8.4 million guaranteed from the Trail Blazers. Their calculated risk isn’t paying off so far. CSN Northwest: Portland Trail Blazers center Festus Ezeli had his left knee injected with a bone marrow aspirate concentrate and Orthovisc today in Chicago. The injection, performed by Dr. Brian Cole, is intended to alleviate pain and improve function. Ezeli will be sidelined for six weeks. This timeline would have Ezeli out for the beginning of training camp but back well before the regular season begins. Even if this puts Ezeli behind